about
Amino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in Rats5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line.Predicting the reactivity of nitrile-carrying compounds with cysteine: a combined computational and experimental studySynthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivoAnandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.Peroxide-Dependent MGL Sulfenylation Regulates 2-AG-Mediated Endocannabinoid Signaling in Brain NeuronsSynthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.Qualitative structure-metabolism relationships in the hydrolysis of carbamates.Epidermal growth factor receptor irreversible inhibitors: chemical exploration of the cysteine-trap portion.Long-lasting inhibition of EGFR autophosphorylation in A549 tumor cells by intracellular accumulation of non-covalent inhibitors.Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides.Dibasic biphenyl H3 receptor antagonists: Steric tolerance for a lipophilic side chain.N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands.On the selection of an opioid for local skin analgesia: Structure-skin permeability relationships.Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.The role of HB-donor groups in the heterocyclic polar fragment of H3-antagonists. I. Synthesis and biological assays.Synthesis, biological activity, QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists.Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities.Antioxidant and cytoprotective activity of indole derivatives related to melatonin.2,4(5)-diarylimidazoles as inhibitors of hNaV1.2 sodium channels: pharmacological evaluation and structure-property relationships.Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor.Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity.Brain pharmacokinetics of non-imidazole biphenyl H3 receptor antagonists: a liquid chromatography/electrospray-mass spectrometry and ex vivo binding study in rats.Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction.Structure–property relationships on histamine H3-antagonists: binding of phenyl-substituted alkylthioimidazole derivatives to rat plasma proteinsN-(2-Oxo-3-oxetanyl)carbamic Acid Esters as N-Acylethanolamine Acid Amidase Inhibitors: Synthesis and Structure–Activity and Structure–Property RelationshipsSynthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groupsCreatine as a compatible osmolyte in muscle cells exposed to hypertonic stressLiquid chromatography-mass spectrometric method for determination of the non-imidazole H3-receptor antagonist UPR1056 in rat plasmaPotent, Metabolically Stable 2-Alkyl-8-(2H-1,2,3-triazol-2-yl)-9H-adenines as Adenosine A2A Receptor LigandsAnalysis of illicit dietary supplements sold in the Italian market: identification of a sildenafil thioderivative as adulterant using UPLC-TOF/MS and GC/MS
P50
Q28548007-BF671EC1-2457-4652-9F41-3B70407B8FDFQ33415749-8D8AF75E-B531-4A7C-8482-6B0C5087B8E8Q33636140-76D62733-8B35-4797-AF9A-DA8AEBDDD51BQ34101852-AEE5A1A0-EBC4-4391-853B-0364F508883DQ34467166-9CE85C43-D1DE-4FC9-9CF4-7580C7DAF71DQ35678770-BAD0995C-9B09-4E62-BD56-5FEFEC1765DDQ35694203-766A0AE9-97BF-4454-8055-5800955DE046Q37098652-3420AFEC-91D5-4A69-9435-89A26D707A97Q37742109-4E3F2A9C-40FB-452B-B389-5C65C14125A3Q37921335-01381A34-CAE2-404B-A16D-F9FBE77712DFQ39103358-421FE903-58FA-4A11-B9BD-35038387B115Q39405800-073B3A42-1A73-441A-BAD1-6F7F7DB90EA2Q39417068-4A4F756A-1261-4571-8119-DF4EC06D3801Q43281456-DED07656-CF7F-497E-8081-A112735B6D34Q44351097-5325521C-20DD-433D-9C16-79A10A8A234DQ44388140-EEA89D1B-775B-4786-8164-FC822CDA26DAQ44588368-0024C0FD-67B4-4ED6-9AA6-DB7BF23358ABQ44753902-A92A4132-741E-49D1-8BDC-713386299C8DQ44763557-5E06B1B0-0970-4F5E-B989-EBBFCEE64706Q44943973-BF980612-8CBD-4A42-8C4C-BDD8D4A44B6FQ46037011-B2685D57-5070-4631-BFC1-B147401EE69EQ46801302-065EFE2A-4D59-4BE0-802B-F905E9D2B2AEQ46961858-4FFD8D52-58FA-4DD9-9B4E-A5CBE35957E4Q48445183-C51097B6-4577-4D1B-A607-CCD050A3641DQ54317185-20267BC9-3774-4D5D-B28C-0C9F9FB26FE6Q61948803-B77C12CC-0730-4BDA-BFCD-200B876A5BACQ63423222-93FEBC2F-9D70-489D-84E6-9F36222A0583Q63423905-5015BA17-A775-4744-966A-E9072A5E7347Q80009916-E74A6D6C-AB22-4E49-88E5-57442A4A93CCQ84291473-DC98D537-8815-49FE-84AC-E0269F1A8633Q87262241-14CEDAFA-0578-4827-8D43-42375076B149Q87812169-8C5B78EA-535C-4F90-B2CB-F2019C68732F
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Federica Vacondio
@ast
Federica Vacondio
@en
Federica Vacondio
@es
Federica Vacondio
@nl
type
label
Federica Vacondio
@ast
Federica Vacondio
@en
Federica Vacondio
@es
Federica Vacondio
@nl
prefLabel
Federica Vacondio
@ast
Federica Vacondio
@en
Federica Vacondio
@es
Federica Vacondio
@nl
P106
P1153
7801421574
P21
P31
P496
0000-0002-0729-4385